FDAnews Device Daily Bulletin

Sept. 26, 2012 | Vol. 9 No. 189

Boston Scientific Launches New Implantable Defibrillation Lead In Europe, Asia

Boston Scientific has received regulatory approval to market the RELIANCE 4-FRONT lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
The Sacramento Bee

Register Now
Print This Page
Email This Article
RSS
Archives

Health Affects Benefits of Implanted Heart Device Trove of Medical Devices Found to Have Password Problems Delcath Faces Investor Ire Following Negative FDA Panel Vote Boston Scientific Begins Patient Enrollment in U.S. Clinical Trial for Use of Vercise DBS System for Parkinson's Disease

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.